In short, the results from our study suggest that the Her-2/neu and TP53 genes are likely to be involved in the beginning of breast carcinogenesis (induction) and undifferentiation of ductal carcinoma in situ, but not in the progression from ductal carcinoma in situ to invasive carcinoma. Here, ERBB2 is linked to ductal breast carcinoma in situ.